A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab

Clinical trial NCT04261439 · TERMINATED

Trial details

NCT number: NCT04261439
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

In Escalation: All Patients With Solid Tumors and Lymphoma In Expansion: Melanoma, Non-small Cell Lung Cancer

Start date: 2020-02-27
Primary completion: 2023-12-27
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.